Overview

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Status:
RECRUITING

Trial end date:
2027-07-06

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous catheter (Phase IIa).

Phase:

PHASE1

Details

Lead Sponsor:

AstraZeneca

Collaborator:

Parexel